- Home
- ITGR vs AXSM Comparison
ITGR vs AXSM Comparison
Compare ITGR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITGR
- AXSM
- Stock Information
- Founded
- ITGR 1970
- AXSM 2012
- Country
- ITGR United States
- AXSM United States
- Employees
- ITGR N/A
- AXSM N/A
- Industry
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- ITGR Health Care
- AXSM Health Care
- Exchange
- ITGR Nasdaq
- AXSM Nasdaq
- Market Cap
- ITGR 4.2B
- AXSM 5.1B
- IPO Year
- ITGR 2000
- AXSM 2015
- Fundamental
- Price
- ITGR $119.95
- AXSM $108.98
- Analyst Decision
- ITGR Strong Buy
- AXSM Strong Buy
- Analyst Count
- ITGR 10
- AXSM 17
- Target Price
- ITGR $145.90
- AXSM $171.65
- AVG Volume (30 Days)
- ITGR 448.0K
- AXSM 665.0K
- Earning Date
- ITGR 07-24-2025
- AXSM 08-04-2025
- Dividend Yield
- ITGR N/A
- AXSM N/A
- EPS Growth
- ITGR N/A
- AXSM N/A
- EPS
- ITGR 2.18
- AXSM N/A
- Revenue
- ITGR $1,746,192,000.00
- AXSM $432,157,000.00
- Revenue This Year
- ITGR $11.03
- AXSM $62.57
- Revenue Next Year
- ITGR $7.29
- AXSM $59.96
- P/E Ratio
- ITGR $54.29
- AXSM N/A
- Revenue Growth
- ITGR 10.19
- AXSM 72.16
- 52 Week Low
- ITGR $104.93
- AXSM $72.21
- 52 Week High
- ITGR $146.36
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- ITGR 49.25
- AXSM 56.00
- Support Level
- ITGR $116.25
- AXSM $102.26
- Resistance Level
- ITGR $122.99
- AXSM $114.66
- Average True Range (ATR)
- ITGR 2.44
- AXSM 3.49
- MACD
- ITGR -0.04
- AXSM 0.92
- Stochastic Oscillator
- ITGR 49.80
- AXSM 61.89
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.